Literature DB >> 22652148

TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease.

Timo Rath1, Katrin Menendez Menendez, Marion Kügler, Lisa Hage, Christian Wenzel, Richard Schulz, Jürgen Graf, Lutz Nährlich, Elke Roeb, Martin Roderfeld.   

Abstract

BACKGROUND: Cystic fibrosis (CF) associated liver disease develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools are lacking. AIMS: We aimed to compare the value of transient elastography and experimental fibrosis markers for the detection of liver disease in CF patients.
METHODS: 145 CF patients (75 children, 70 adults) were prospectively studied and received transient elastography. CF liver disease was diagnosed according to recent guidelines. Serum concentrations of YKL-40, HA, PIIIP, MMP-9, TIMP-1 and TIMP-2 were determined by ELISA.
RESULTS: Transient elastography was increased in adults and children with CF hepatopathy compared to those without and exhibited a high diagnostic accuracy for CF liver disease. In adults with portal hypertension, elastography was further enhanced. TIMP-2 was elevated in adults with CF hepatopathy associated portal hypertension and exhibited a high diagnostic accuracy for portal hypertension in adults and for CF hepatopathy in children. TIMP-1 had a high diagnostic accuracy for CF hepatopathy in adults. Diagnostic sensitivities were increased when elastography and respective biomarkers were combined for the detection of CF hepatopathy and portal hypertension.
CONCLUSIONS: TIMP-1 and TIMP-2 represent powerful biomarkers for CF associated liver disease and portal hypertension. Their determination may confirm and improve the diagnostic accuracy of transient elastography.
Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652148     DOI: 10.1016/j.dld.2012.04.008

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  13 in total

1.  Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

Authors:  Matthew D Sadler; Pam Crotty; Linda Fatovich; Stephanie Wilson; Harvey R Rabin; Robert P Myers
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

2.  Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.

Authors:  Gamal Shiha; Alaa Ibrahim; Ahmed Helmy; Shiv Kumar Sarin; Masao Omata; Ashish Kumar; David Bernstien; Hitushi Maruyama; Vivek Saraswat; Yogesh Chawla; Saeed Hamid; Zaigham Abbas; Pierre Bedossa; Puja Sakhuja; Mamun Elmahatab; Seng Gee Lim; Laurentius Lesmana; Jose Sollano; Ji-Dong Jia; Bahaa Abbas; Ashraf Omar; Barjesh Sharma; Diana Payawal; Ahmed Abdallah; Abdelhamid Serwah; Abdelkhalek Hamed; Aly Elsayed; Amany AbdelMaqsod; Tarek Hassanein; Ahmed Ihab; Hamsik GHaziuan; Nizar Zein; Manoj Kumar
Journal:  Hepatol Int       Date:  2016-10-06       Impact factor: 6.047

Review 3.  Cystic fibrosis liver disease: A condition in need of structured transition and continuity of care.

Authors:  Julian Hercun; Fernando Alvarez; Catherine Vincent; Marc Bilodeau
Journal:  Can Liver J       Date:  2019-08-27

4.  Oxidative stress and extracellular matrices after hepatectomy and liver transplantation in rats.

Authors:  Tomohide Hori; Shinji Uemoto; Feng Chen; Lindsay B Gardner; Ann-Marie T Baine; Toshiyuki Hata; Takayuki Kogure; Justin H Nguyen
Journal:  World J Hepatol       Date:  2014-02-27

Review 5.  Cystic fibrosis from the gastroenterologist's perspective.

Authors:  Chee Y Ooi; Peter R Durie
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-21       Impact factor: 46.802

Review 6.  Cirrhosis and other liver disease in cystic fibrosis.

Authors:  Thomas Flass; Michael R Narkewicz
Journal:  J Cyst Fibros       Date:  2012-12-20       Impact factor: 5.482

7.  Cystic fibrosis and noninvasive liver fibrosis assessment methods in children.

Authors:  Raphael Enaud; Eric Frison; Sophie Missonnier; Aude Fischer; Victor de Ledinghen; Paul Perez; Stéphanie Bui; Michael Fayon; Jean-François Chateil; Thierry Lamireau
Journal:  Pediatr Res       Date:  2021-03-17       Impact factor: 3.953

8.  Transient Elastography in the Evaluation of Cystic Fibrosis-Associated Liver Disease: Systematic Review and Meta-analysis.

Authors:  Simon Lam; Alberto Nettel-Aguirre; Stephanie Van Biervliet; Elke Roeb; Matthew D Sadler; Mireen Friedrich-Rust; Thomas Karlas; Matthew T Kitson; Jennifer C C deBruyn
Journal:  J Can Assoc Gastroenterol       Date:  2018-07-09

9.  Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.

Authors:  Timo Rath; Lisa Hage; Marion Kügler; Katrin Menendez Menendez; Reinhart Zachoval; Lutz Naehrlich; Richard Schulz; Martin Roderfeld; Elke Roeb
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.

Authors:  Victoria Klotter; Caroline Gunchick; Enno Siemers; Timo Rath; Helge Hudel; Lutz Naehrlich; Martin Roderfeld; Elke Roeb
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.